The shake-up of Swiss drug major Roche's R&D capabilities (see page 2) saw a number of personnel changes: Jonathan Knowles, president of global research, will now focus on his role as head of group research, responsible for coordinating R&D across all of Roche's units; Lee Babiss, currently research site head in Nutley, New Jersey, USA, has been promoted to head of Roche Pharma Research; and, as previously announced, Eduard Holdener will retire at the end of 2007. His role as head of global pharmaceutical development was taken over by Jean-Jacques Garaud at the start of this year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze